Literature DB >> 28705797

Cyclical Cushing's: how best to catch the ups and downs.

Malik Asif Humayun1, Tanya Hart2, Tristan Richardson3.   

Abstract

A 68-year-old man with a background of hypertension and type 2 diabetes presented with fluctuating symptoms of muscle aches and pains and tiredness. His initial work-up for the possibility of hypercortisolaemia showed a completely variable pattern, with 24-hour cortisol excretion and serum cortisol post 1 mg dexamethasone suppression test ranging from normal to significantly elevated. A series of salivary cortisol with symptom diary confirmed the cyclical nature of hypercortisolaemia, and his concomitant adrenocorticotropic hormone (ACTH) levels were elevated. An inferior petrosal sinus sampling, performed during hypercortisolaemic phase of his cycle,suggested a central source of ACTH secretion. He had unsuccessful exploration of his pituitary and was eventually treated with bilateral adrenalectomy followed by lifelong steroid replacement. His symptoms improved immediately, and he came off his oral hypoglycaemic and antihypertensive agents within 6 months following his surgery. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  drugs and medicines; endocrinology; interventional cardiology

Mesh:

Substances:

Year:  2017        PMID: 28705797      PMCID: PMC5534865          DOI: 10.1136/bcr-2016-218451

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

Review 2.  Cyclic Cushing's syndrome: an overview.

Authors:  Franco Mantero; Carla M Scaroni; Nora M E Albiger
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

3.  Cyclical Cushing's syndrome due to an atypical thymic carcinoid.

Authors:  J R Meinardi; G van den Berg; B H R Wolffenbuttel; I P Kema; R P F Dullaart
Journal:  Neth J Med       Date:  2006-01       Impact factor: 1.422

4.  What is the best approach to suspected cyclical Cushing syndrome? Strategies for managing Cushing's syndrome with variable laboratory data.

Authors:  Brew Atkinson; Karen R Mullan
Journal:  Clin Endocrinol (Oxf)       Date:  2011-07       Impact factor: 3.478

Review 5.  Cyclic Cushing's syndrome: a clinical challenge.

Authors:  J R Meinardi; B H R Wolffenbuttel; R P F Dullaart
Journal:  Eur J Endocrinol       Date:  2007-09       Impact factor: 6.664

6.  A novel tool in the diagnosis and follow-up of (cyclic) Cushing's syndrome: measurement of long-term cortisol in scalp hair.

Authors:  L Manenschijn; J W Koper; E L T van den Akker; L J M de Heide; E A M Geerdink; F H de Jong; R A Feelders; E F C van Rossum
Journal:  J Clin Endocrinol Metab       Date:  2012-07-27       Impact factor: 5.958

Review 7.  Cyclic Cushing's syndrome: an overview.

Authors:  Nora Maria Elvira Albiger; Carla M Scaroni; Franco Mantero
Journal:  Arq Bras Endocrinol Metabol       Date:  2007-11

8.  Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes.

Authors:  Maria Yaneva; Helen Mosnier-Pudar; Marie-Annick Dugué; Sophie Grabar; Yvonne Fulla; Xavier Bertagna
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

9.  The prevalence and characteristic features of cyclicity and variability in Cushing's disease.

Authors:  Krystallenia I Alexandraki; Gregory A Kaltsas; Andrea M Isidori; Scott A Akker; William M Drake; Shern L Chew; John P Monson; G Michael Besser; Ashley B Grossman
Journal:  Eur J Endocrinol       Date:  2009-03-16       Impact factor: 6.664

10.  Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide study.

Authors:  James W Findling; Maria Fleseriu; John Newell-Price; Stephan Petersenn; Rosario Pivonello; Albert Kandra; Alberto M Pedroncelli; Beverly M K Biller
Journal:  Endocrine       Date:  2016-05-21       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.